RoxanaSDroncaMD

PubMed

• 1 citations
  Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
  Domingo-Musibay, E., Hieken, T., Nelson, G., Flotte, T., Grewal, E., Chen, J., McWilliams, R., Kottschade, L., Yang, L., Domingo-Musibay, E., Dronca, R., Yan, Y., Mark...> ;Nature Communications. 2024 Feb 16
• A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate canc...
  Mosalem, O., Tan, W., Bryce, A., Dronca, R., Childs, D., Pagliaro, L., Orme, J., Kase, A.> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 10
• 2 citations
  Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.
  Yan Luo, Yaqing Qie, Martha E Gadd, Alak Manna, Rocio Rivera-Valentin, Tommy To, Shuhua Li, Farah Yassine, Hemant S Murthy, Roxana Dronca, Mohamed A Kharfan-Dabaja, Ho...> ;Cancer Immunology, Immunotherapy. 2023 Dec 1
• 4 citations
  Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021.
  Joshua C Pritchett, Bijan J Borah, Ruchita Dholakia, James P Moriarty, Hannah H Ahn, Ming Huang, Nandita Khera, Laurie Wilshusen, Roxana S Dronca, Jonathan Ticku, Aaro...> ;JCO Oncology Practice. 2023 Sep 1
• 1 citations
  Post-Autologous Hematopoietic Cell Transplant Care in the "Home Sweet Home" Setting: A Treatment Paradigm Shift.
  Mohamed A Kharfan-Dabaja, Vivek Roy, Hemant Murthy, Deborah Fischer, Razan Mohty, Ashley Greathouse, Alethea Brown, Kathryn Moreno, Emily Godsey, Jennifer M Higginboth...> ;Hematology/oncology and Stem Cell Therapy. 2023 May 23
• 1 citations
  Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program.
  Esplin, E. D., Jeremy C Jones, Michael A Golafshar, Tucker W Coston, Rohit Rao, Ewa Wysokinska, Elizabeth Johnson, Edward D Esplin, Robert L Nussbaum, Brandie Heald, M...> ;Cureus. 2023 Apr 1
• A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intra...
  Katherine E R Smith, Kah-Whye Peng, Jose S Pulido, Adam J Weisbrod, Carrie A Strand, Jacob B Allred, Alysha N Newsom, Lianwen Zhang, Nandakumar Packiriswamy, Timothy K...> ;Frontiers in Immunology. 2023 Jan 1
• 13 citations
  NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
  Ti Wen, Whitney Barham, Ying Li, Henan Zhang, Joanina K Gicobi, Jacob B Hirdler, Xin Liu, Hyoungjun Ham, Kodi E Peterson Martinez, Fabrice Lucien, Roxane R Lavoie, Hu ...> ;Cancer Immunology Research. 2022 Feb 1
• 15 citations
  Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications.
  Karim ReFaey, Shashwat Tripathi, Sanjeet S. Grewal, Adip G. Bhargav, David J. Quinones, Kaisorn L. Chaichana, Samuel O. Antwi, Leslie T. Cooper, Fredric B. Meyer, Roxa...> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2021 Jun 1
• 48 citations
  Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma.
  , , , , , , , , , , , , , , , , , , , , , > ;European Journal of Cancer. 2021 Feb 1
• 5 citations
  Peptide vaccine with glucopyranosyl lipid A-stable oil-in-water emulsion for patients with resected melanoma.
  Eric P. Grewal, Courtney L Erskine, Wendy K. Nevala, Jacob B Allred, Carrie A Strand, Lisa A. Kottschade, Robert R. McWilliams, Roxana S. Dronca, Adam Yakovich, Svetom...> ;Immunotherapy. 2020 Aug 5
• 31 citations
  Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles.
  Jacob J. Orme, Elizabeth Ann L. Enninga, Fabrice Lucien-Matteoni, Heather Dale, Edwin A. Burgstaler, Susan M. Harrington, Matthew K. Ball, Aaron S. Mansfield, Sean S. ...> ;Journal for Immunotherapy of Cancer. 2020 Aug 1
• 30 citations
  Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
  Jesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams, Henan Zhang, Ying Li, Anagha Bangalore Kumar, Jarrett J. Failing, Lisa A. Kottschade, Matthew S. Block, Svetom...> ;Melanoma Research. 2020 Aug 1
• 67 citations
  ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance.
  Jacob J. Orme, Khalid Jazieh, Tiancheng Xie, Susan M. Harrington, Xin Liu, Matthew K. Ball, Benjamin J. Madden, M. Cristine Charlesworth, Tariq U. Azam, Fabrice Lucien...> ;Oncoimmunology. 2020 Apr 14
• 15 citations
  Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.
  Thomas DeLeon, Daniel R. Almquist, Benjamin R. Kipp, Blake T. Langlais, Aaron R. Mangold, Jennifer L. Winters, Heidi E. Kosiorek, Richard W. Joseph, Roxana S. Dronca, ...> ;Plos One. 2020 Mar 20
• In Reply - Immune Checkpoint Inhibitor-Induced Type 1 Diabetes: An Underestimated Risk.
  Julian A. Marin-Acevedo, Razvan M. Chirila, Roxana S. Dronca> ;Mayo Clinic Proceedings. 2020 Mar 1
• 15 citations
  Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
  Tina J. Hieken, Amy E. Glasgow, Elizabeth Ann L. Enninga, Lisa A. Kottschade, Roxana S. Dronca, Svetomir N. Markovic, Matthew S. Block, Elizabeth B. Habermann> ;Journal of Women's Health. 2020 Sep 14
• 22 citations
  Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
  Sandhya Manohar, Ranine Ghamrawi, Madhuri Chengappa, Busra N Bacik Goksu, Lisa Kottschade, Heidi Finnes, Roxana Dronca, Konstantinos Leventakos, Joerg Herrmann, Sandra...> ;Kidney360. 2020 Jan 30
• 73 citations
  Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?
  Narjust Duma, Azzouqa Abdel‐Ghani, Siddhartha Yadav, Katherine P. Hoversten, Clay T Reed, Andrea N. Sitek, Elizabeth Ann L. Enninga, Jonas Paludo, Jesus Vera Aguilera,...> ;The Oncologist. 2019 Apr 29
• 11 citations
  Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy.
  Jarrett J. Failing, Olivia A Dudek, Julian A Marin Acevedo, Razvan M. Chirila, Haidong Dong, Svetomir N. Markovic, Roxana S. Dronca> ;Future Oncology. 2019 Jul 12
• 4 citations
  Paradox-driven adventures in the development of cancer immunology and immunotherapy
  Whitney Barham, Joanina K. Gicobi, Yiyi Yan, Roxana S. Dronca, Haidong Dong> ;Genes & Diseases. 2019 Jul 10
• 86 citations
  Immune Checkpoint Inhibitor Toxicities
  Julian A. Marin-Acevedo, Razvan M. Chirila, Roxana S. Dronca> ;Mayo Clinic Proceedings. 2019 Jul 1
• 543 citations
  Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
  , , , , , , , , , , , , , , , , , , > ;Annals of Oncology. 2019 Apr 1
• 4 citations
  Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.
  Jesus Vera, Jonas Paludo, Lisa A. Kottschade, Jessica Brandt, Yiyi Yan, Matthew S. Block, Robert R. McWilliams, Roxana S. Dronca, Charles L. Loprinzi, Axel Grothey, Sv...> ;Supportive Care in Cancer. 2019 Feb 14
• 18 citations
  Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT.
  Jaden D. Evans, Lindsay Kaye Morris, Henan Zhang, Siyu Cao, Xin Liu, Kristin C. Mara, Bradley J. Stish, Brian J. Davis, Aaron S. Mansfield, Roxana S. Dronca, Matthew J...> ;International Journal of Radiation Oncology, Biology, Physics. 2019 Jan 1
• Join now to see all